对静脉变的潜在药物点的识别:孟德尔的随机化分析
Jianfeng Lin1, Jiawei Zhou2, Zhili Liu2
1Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Frontiers in cardiovascular medicine
|July 5, 2023
概括
这项研究使用了门德尔的随机化来识别与静脉变相关的八种血蛋白. 五种蛋白质可能具有保护作用,而包括IRF3在内的三种蛋白质可能是新的静脉缩治疗的潜在治疗点.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 血管生物学 血管生物学
- 药物基因组学 药物基因组学
背景情况:
- 静脉静脉代表着严重的医疗负担,有效的治疗方法有限.
- 目前治疗静脉的疗法缺乏向疗效,需要新的治疗策略.
- 门德尔随机化 (MR) 是一种强大的遗传方法,用于识别因果关系和潜在的药物标.
研究的目的:
- 使用双样本门德尔随机化 (MR) 方法,选血蛋白作为缩静脉的潜在药物标.
- 为了确定静脉的因果蛋白标,并评估它们的潜在治疗效用.
- 通过全现象MR来评估已识别的蛋白质标的潜在不良影响.
主要方法:
- 采用两样 MR 设计,使用 2,004 个血蛋白的 cis 变异作为仪器变量.
- 将MR分析应用于一个大型全基因组关联研究 - - 静脉静脉的元分析 (22,037例,437,665对照).
- 为了安全性评估,进行了类型检测,反向因果关系测试,局部化,外部复制和全现象MR (PheW-MR).
主要成果:
- 鉴定出八种与静脉静脉风险显著相关的血蛋白 (邦费罗尼校正P <2.495 × 10−5).
- 五种蛋白质 (LUM,POSTN,RPN1,RSPO3,VAT1) 显示出一种保护性关联,而三种 (COLEC11,IRF3,SARS2) 与增加风险有关.
- 通过PheW-MR发现的唯一具有潜在不良副作用的优先级蛋白质是IRF3;同位化证实了六种蛋白质的共同因果变异.
结论:
- 通过MR识别出八种血蛋白质是通过MR发展静脉的潜在因果因素.
- IRF3,LUM,POSTN,RSPO3和SARS2成为新型静脉瘤治疗的有希望的治疗标.
- 对这些蛋白质的进一步研究可能会导致更有效,更有针对性的静脉缩疗法.
相关概念视频
01:26Varicose Veins I: Introduction
11
Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
11
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
15
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
15
01:24Esophageal Varices-I: Introduction
198
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
198
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
14
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
14
01:28Esophageal Varices-II: Clinical Features and Management
99
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
99
01:29Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10